Ottawa, Canada – April 15, 2014 – The Canadian Foundation for Healthcare Improvement today launched a pan-Canadian collaborative focused on improving care for patients with chronic obstructive pulmonary disease (COPD), supported by Boehringer Ingelheim (Canada) Ltd. (BICL). The collaborative will assist healthcare organizations to adapt and implement an innovative approach to COPD developed at Capital Health, Nova Scotia, that helped improve patient care, support families and caregivers, significantly reduce the use of acute care services and lower costs.
“Our Government is committed to supporting innovative partnerships that improve care for patients,” said the Honourable Rona Ambrose, Federal Minister of Health. “Through funding for the Canadian Foundation for Healthcare Improvement, we are helping healthcare organizations across the country implement best practices in COPD care via this unique partnership.”
INSPIRED (Implementing a Novel and Supportive Program of Individualized Care for patients and families living with REspiratory Disease) is a hospital-to-home, coordinated and proactive approach to care and advanced COPD. The program provides patients and their families with self-management education, psychosocial and spiritual care support and advance care planning. Six months after enrolment in the program at Capital Health’s Queen Elizabeth II Health Sciences Centre, INSPIRED patients’ ER visits, hospitalizations and lengths of stay fell by more than 60 percent. In 2014, INSPIRED received an Accreditation Canada Leading Practice designation as a noteworthy example of high-quality leadership and service delivery in COPD care.
“INSPIRED is an innovative way of providing better patient care that is also more cost effective,” said CFHI President Maureen O’Neil. “CFHI is pleased to be working with our Clinical Improvement Advisor, Dr. Graeme Rocker and Boehringer Ingelheim to help spread this approach to COPD care.”
Respirologist and CFHI Clinical Improvement Advisor Dr. Graeme Rocker, Respiratory Therapist Ms. Joanne Michaud-Young and Spiritual Care Practitioner Dr. Cathy Simpson developed and implemented INSPIRED after noting that current models of care were largely reactive, under stress and failing, with significant costs to patients, families and the healthcare system.
“This program restores the dignity of the patient and family during late stages of COPD and through end-of-life care,” said Dr. Rocker. “We are delighted to have the opportunity to share our successful experience with others through CFHI’s novel collaborative.”
COPD is the fourth-leading cause of death in Canada and a primary cause of hospital visits. Based on recent estimates, COPD exacerbations cost Canadian healthcare systems more than $750-million a year, not including routine care.
“Boehringer Ingelheim is pleased to be a part of this unique program that will address the underlying unmet needs of patients and their families living with moderate to severe COPD,” said Richard Mole, President and CEO, Boehringer Ingelheim (Canada) Ltd. “This program will offer a fully integrated approach to COPD care and support while also improving the patient experience.”
Under the partnership agreement, BICL will provide direct funding to CFHI to support the collaborative. The partnership will enable teams to take advantage of educational resources and other capacity building supports. In addition, CFHI and BICL will partner with the Alberta-based Institute of Health Economics (IHE) to undertake complementary policy and economic analyses.
CFHI is providing funding and other support to help teams from across Canada implement INSPIRED-like approaches to COPD care. This is the second of two collaboratives in CFHI’s recently launched Spreading Healthcare Innovations Initiative. The first collaborative focuses on reducing inappropriate antipsychotic medication use in long term care.
For more information, please contact:
Senior Communications Specialist
Canadian Foundation for Healthcare Improvement
W: 613-728-2238 ext. 288